Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program

Vox Sanguinis

Volumn 77, Issue 1, 1999, Pages 24-32

  Despotis, George J ^a   Goodnough, L T ^a   Dynis, M ^a   Baorto, D ^a   Spitznagel, E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITRIC ACID;

ADULT; ARTICLE; BLOOD DONOR; BODY WEIGHT; CONTROLLED STUDY; DATA BASE; EMERGENCY WARD; FEMALE; GENDER; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SKIN MANIFESTATION; SYNCOPE; THROMBOCYTOPHERESIS; TOXICITY; VEIN PUNCTURE;

ADULT; BLOOD DONORS; CARDIOVASCULAR DISEASES; CITRIC ACID; CORONARY DISEASE; DEMOGRAPHY; HOSPITAL DEPARTMENTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MISSOURI; MULTIVARIATE ANALYSIS; OVERDOSE; PLATELETPHERESIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0032840255     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031070     Document Type: Article

References (26)

1. Devine P, Goldstein R, Linden JV, Postoway N, Hoffstadter LK, Hines DM: Data on apheresis, blood collection, and transfusion-related activities: Statistical analyses of the American Association of Blood Banks institutional membership questionnaires. Transfusion 1996;36: 375-381.
2. Wallace EL, Churchill WH, Surgenor DM, Cho GS, McGurk S: Collection and transfusion of blood and blood components in the United States, 1994. Transfusion 1998;38: 625-636.
3. Rock G, Sutton DMC: Apheresis: Man versus machine. Transfusion 1997;37:993-995.
4. Robinson EA: Donor and therapeutic apheresis; in Tawes RL (ed): Autotransfusion: Therapeutic Principles and Trends. Detroit, Gregory Appleton, 1997, pp 12-23.
5. Mcleod BC, Price TH, Owen H, Ciavarella D, Sniecinski I, Randels MJ, Smith JW: Frequency of immediate adverse effects associated with apheresis donation. Transfusion 1998;38: 938-943.
6. Popovsky MA, Whitaker B, Arnold NL: Severe outcomes of allogeneic and autologous blood donation: Frequency and characterization. Transfusion 1995;35:734-737.
7. Sutton DM, Nair RC, Rock G: Complications of plasma exchange. Transfusion 1989;29: 124-127.
8. Gutensohn K, Bartsch N, Kuehnl P: Flow cytometric analysis of platelet membrane antigens during and after continous-flow platelet-pheresis. Transfusion 1997;37:809-815.
9. Wun T, Paglieroni T, Holland P: Prolonged circulation of activated platelets following plasmapheresis. J Clin Apheresis 1994;9:10-16.
10. Wun T, Paglieroni T, Sazama K, Holland P: Detection of plasmapheresis-induced platelet activation using monoclonal antibodies. Transfusion 1992;32:534-540.
11. Gutensohn K, Maerz M, Kuehnl P: Alteration of platelet-associated membrane glycoproteins during extracorporeal apheresis of peripheral blood progenitor cells. J Hematother 1997;6: 315-321.
12. Stohlawetz P, Hergovich N, Stiegler G, Eichler HG, Hocker P, Kapiotis S, Jilma B: Differential induction of P-selectin expression on platelets by two cell separators during platelet-pheresis and the effect of gender on the release of soluble P-selectin. Transfusion 1998;38:24-30.
13. Courtney JM, Lamba NM, Sundaram S, Forbes CD: Biomaterials for blood-contacting applications. Biomaterials 1994;15:737-744.
14. Haycox CL, Ratner BD: In vitro platelet interactions in whole human blood exposed to biomaterial surfaces: Insights on blood compatibility. J Biomed Mater Res 1993;27:1181-1193.
15. Hellmus JD, Hardwick RA: Response of platelets to shear stress: A review; in Gross DR, Hwang NHC (eds): The Rheology of Blood, Blood Vessels and Associated Tissues. Alphen aan den Rijn. Siijthoff en Noordhoff, 1981, pp 160-183.
16. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR: Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991;75:563-570.
17. Boogaerts MA: Side effects of hemapheresis. Transfus Med Rev 1987;1:186-194.
18. Strauss RG: Mechanisms of adverse effects during hemapheresis. J Clin Apheresis 1996; 11:160-164.
19. Szymanski IO: Ionized calcium during plateletpheresis. Transfusion 1978;18:701-708.
20. Uhl L, Maillet S, King S, Kruskall MS: Unexpected citrate toxicity and severe hypocalcemia during apheresis. Transfusion 1997; 37:1063-1065.
21. Korach JM, Bussel A, Gajdos P: The national survey of plasma exchange and therapeutic cytapheresis in France. Registry Study Group. Transfus Sci 1995;16:363-370.
22. Bunker JP, Bendixen HH, Murphy AJ: Hemodynamic effects of intravenously administered sodium citrate. N Engl J Med 1962;266: 372-377.
23. Olson PR, Cox C, McCullough J: Laboratory and clinical effects of the infusion of ACD solution during plateletpheresis. Vox Sang 1977;33:79-87.
24. Cassidy MJD, Wood L, Jacobs P: Hypocalcernia during plateletpheresis. Transfus Sci 1990;11:217-221.
25. Farrokhi P, Farahmond H, Bismuth A, Suarez C, Ducot B, Gillon C, Debat P, Laskowski P, Pinon F: How to stabilize the level of ionized calcium and citrate during plateletpheresis. Vox Sang 1998;74:7-12.
26. Bertholf MF, Mintz PD: Comparison of plateletpheresis using two cell separators and identical donors. Transfusion 1989;29:521-523.